CG Oncology (CGON) Asset Utilization Ratio (2024 - 2026)

CG Oncology (CGON) posted Asset Utilization Ratio of 0.01 for Q1 2026, down 0.89% on a QoQ basis from 0.01 in Q4 2025, and up 489.55% year-over-year from 0.0 in Q1 2025.

CG Oncology (CGON) Asset Utilization Ratio (2024 - 2026) Analysis & Trends

CG Oncology's Asset Utilization Ratio history runs 3 years deep, the most recent figure standing at 0.01 for Q1 2026.

  • Quarterly Asset Utilization Ratio rose 489.55% year-over-year to 0.01 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.01 (up 489.55% YoY) and the FY2025 annual result came in at 0.01, up 118.84% from the prior year.
  • Asset Utilization Ratio was 0.01 for Q1 2026 at CG Oncology, down from 0.01 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.01 in Q4 2025 and bottomed at 0.0 in Q2 2025.
  • A 3-year average of 0.0 and a median of 0.0 in 2024 frame the typical range for Asset Utilization Ratio.
  • Annual changes were most pronounced in 2025 — Asset Utilization Ratio sank 35.53% — and 2026, when it jumped 489.55%.
  • CG Oncology's Asset Utilization Ratio stood at 0.0 in 2024, then soared by 204.75% to 0.01 in 2025, then decreased by 0.89% to 0.01 in 2026.
  • Business Quant data shows CGON's Asset Utilization Ratio at 0.01 in Q1 2026, 0.01 in Q4 2025, and 0.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.69
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 0.47
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 0.37
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 CG Oncology 6.01 Bn 6.01 Bn -1.88 Mn 0.01

Historic Data

Download Data
DateValue
Mar 31, 2026 0.01
Dec 31, 2025 0.01
Sep 30, 2025 0.00
Jun 30, 2025 0.00
Mar 31, 2025 0.00
Dec 31, 2024 0.00
Sep 30, 2024 0.00
Jun 30, 2024 0.00
Mar 31, 2024 0.00